Barbarash O.L., Osokina A.V. The role of markers of CD40 / CD40L system in prediction of cardiovascular events in coronary atherosclerosis. Patologiya krovoobrascheniya I kardiokhirurgiya = Pathology of blood circulation and cardiac surgery. 2011. (3). 89-93. [In Russian].
Bibek S.B., Xie Y., Gao J.J., Wang Z., Wang J.F., Geng D.F. Role of pre-procedural C-reactive protein level in the prediction of major adverse cardiac events in patients undergoing percutaneous coronary intervention: a meta-analysisof longitudinal studies // Inflammation. 2015. 38. (1). 159-169.
Blankenberg S., Rupprecht H.J., Poirier O., Bickel C., Smieja M., Hafner G., Meyer J., Cambien F., Tiret L. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease // Circulation. 2003. 107. 1579–1585.
Bourantas C.V., Papafaklis M.I., Garcia-Garcia H.M., Farooq V., Diletti R., Muramatsu T., Zhang Y., Kalatzis F.G., Naka K.K., Fotiadis D.I., Onuma Y., Michalis L.K., Serruys P.W. Short- and long-term implications of a bioresorbable vascular scaffold implantation on the local endothelial shear stress patterns // JACC Cardiovasc. Interv. 2014. 7. (1). 100-101.
Finn A.V., Kolofgie F.D., Harnek J. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents // Circulation. 2005. 112. (2). 270-78.
Gao J., Liu Y., Cui R.Z., Mao Y.M., Zhou J., Chen Q., Zhao F.M., Yang G.M. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis // Chin. Med. J. 2013. 126. (6). 1019-1025.
Katsaros K.M., Kastl S.P., Zorn G., Maurer G., Wojta J., Huber K., Christ G., Speidl W.S. Increased restenosis rate after implantation of drug-eluting stents in patients with elevated serum activity of matrix metalloproteinase-2 and -9 // JACC Cardiovasc. Interv. 2010. 3. (1). 90-97.
Pasceri V., Willerson J.T., Yeh E.T. Direct proinflammatory effect of C-reactive protein on human endothelial cells // Circulation. 2000. 102. (6). 2165-2168.
Plechev V.V., Nikolaeva I.E., Buzaev I.V., Zagitov I.G., Rizberg R.Yu., Yamanaeva I.E. Bioresorbable intravascular scaffolds. Review article. Kreativnaya khirurgiya i onkologiya = Creative Surgery and Oncology. 2017. 7. (4). 53-62. [In Russian].
Proskuriakov A.I., Mironenko S.P., Osiev A.G. Clinical and immunological aspects of restenosis formation after coronary stenting in CAD. Meditsina i obrazovanie v Sibiri = Medicine and education in Siberia. 2013. (3). https://readera.ru/14299210. [In Russian].
Samady H., Eshtehardi P., McDaniel M.C., Suo J., Dhawan S.S., Maynard C., Timmons L.H., Quyyumi A.A., Giddens D.P. Coronary artery wall shear stress is associated with progression and transformation of atherosclerotic plaque and arterial remodeling in patients with coronary artery disease // Circulation. 2011. 124. (7). 779-788.
Semenikhin A.A., Grachev N.I., Markelova E.V., Turmova E.P. Analysis of immuno-biochemical markers in the development of restenosis after coronary stenting in patients with stable angina. Zdorov'ye i obrazovaniye v XXI veke = Health and education in the 21st century. 2016. 18. (2). 626-635. [In Russian].
Serruys P.W, Garcia-Garcia H.M, Onuma Y. From metallic cages to transient bioresorbable scaffolds: Change in paradigm of coronary revascularization in the upcoming decade? // Eur Heart J. 2012. 33. (1). 16-25.
Simon D.I. Inflammation and vascular injury: basic discovery to drug development // Circ. J. 2012. 76. 1811-1818.
Sorrentino S., Giustino G., Mehran R., Kini A.S., Sharma S.K., Faggioni M., Farhan S., Vogel B., Indolfi C., Dangas G.D. Everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents // J. Am. Coll. Cardiol. 2017. 69. (25). 3055-3066.
Tuomisto K., Jousilahti P., Sundvall J., Pajunen P., Salomaa V. C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study // Thromb. Haemost. 2006. 95. (3). 511-518.
Walter D.H., Fichtlschere S., Sellwig M., Auch-Schwelk W., Schachinger V., Zeiher A.M. Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation // J. Am. Coll. Cardiol. 2001. 37. 839-846.
Williams N., Bertoncello I., Jackson H., Arnold J., Kavnoudias H. The role of interleukin 6 in megakaryocyte formation, megakaryocyte development and platelet production // Ciba Found Symp. 1992. 167. 160-170.